X
X4 Pharmaceuticals, Inc.
XFOR · NASDAQ · Healthcare · 398M
Closing price
$2.91
+4.30% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
0.2×
Free cash flow yieldFCF yield
-72.0%
Return on equityROE
-42.5%
Operating margin
-247.4%
Net debt / EBITDAbalance-sheet strength
2.0×
Interest coverage
-9.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.